Catalys Pacific Fund, LP

Insider profile

Catalys Pacific Fund, LP's trades of Mineralys Therapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
363.18
Quantity 22,621
Value US$2,547,109
Transaction date
Proposed sale
Price
349.06
Quantity 29,707
Value US$4,490,847
Transaction date
Proposed sale
Price
482.18
Quantity 11,335
Value US$396,670
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-22 2026-09-22 PrS Proposed sale
22,621
363.18
US$2,547,109
22,621 363.18 US$2,547,109
2025-11-20 2025-11-20 PrS Proposed sale
29,707
349.06
US$4,490,847
29,707 349.06 US$4,490,847
2024-07-24 2024-07-24 PrS Proposed sale
11,335
482.18
US$396,670
11,335 482.18 US$396,670